Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

930 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment.
Araki W, Kanemaru K, Hattori K, Tsukamoto T, Saito Y, Yoshida S, Takano H, Sakata M, Yokoi Y, Omachi Y, Nagaoka U, Nagao M, Komori T, Tachimori H, Murayama S, Mizusawa H. Araki W, et al. Among authors: sakata m. Aging Clin Exp Res. 2022 Feb;34(2):341-347. doi: 10.1007/s40520-021-01935-7. Epub 2021 Jul 20. Aging Clin Exp Res. 2022. PMID: 34283410
Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
Omachi Y, Ito K, Arima K, Matsuda H, Nakata Y, Sakata M, Sato N, Nakagome K, Motohashi N. Omachi Y, et al. Among authors: sakata m. Psychiatry Clin Neurosci. 2015 Dec;69(12):741-51. doi: 10.1111/pcn.12326. Epub 2015 Jul 30. Psychiatry Clin Neurosci. 2015. PMID: 26085054 Free article.
Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study.
Sone D, Imabayashi E, Maikusa N, Okamura N, Furumoto S, Kudo Y, Ogawa M, Takano H, Yokoi Y, Sakata M, Tsukamoto T, Kato K, Matsuda H. Sone D, et al. Among authors: sakata m. Alzheimers Dement (Amst). 2017 Aug 4;9:35-40. doi: 10.1016/j.dadm.2017.07.001. eCollection 2017. Alzheimers Dement (Amst). 2017. PMID: 28856235 Free PMC article.
Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders.
Araki W, Hattori K, Kanemaru K, Yokoi Y, Omachi Y, Takano H, Sakata M, Yoshida S, Tsukamoto T, Murata M, Saito Y, Kunugi H, Goto YI, Nagaoka U, Nagao M, Komori T, Arima K, Ishii K, Murayama S, Matsuda H, Tachimori H, Araki YM, Mizusawa H. Araki W, et al. Among authors: sakata m. Biomark Res. 2017 Sep 22;5:28. doi: 10.1186/s40364-017-0108-5. eCollection 2017. Biomark Res. 2017. PMID: 29018524 Free PMC article.
Dissociation of Tau Deposits and Brain Atrophy in Early Alzheimer's Disease: A Combined Positron Emission Tomography/Magnetic Resonance Imaging Study.
Shigemoto Y, Sone D, Imabayashi E, Maikusa N, Okamura N, Furumoto S, Kudo Y, Ogawa M, Takano H, Yokoi Y, Sakata M, Tsukamoto T, Kato K, Sato N, Matsuda H. Shigemoto Y, et al. Among authors: sakata m. Front Aging Neurosci. 2018 Jul 18;10:223. doi: 10.3389/fnagi.2018.00223. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30072890 Free PMC article.
Association of deposition of tau and amyloid-β proteins with structural connectivity changes in cognitively normal older adults and Alzheimer's disease spectrum patients.
Shigemoto Y, Sone D, Maikusa N, Okamura N, Furumoto S, Kudo Y, Ogawa M, Takano H, Yokoi Y, Sakata M, Tsukamoto T, Kato K, Sato N, Matsuda H. Shigemoto Y, et al. Among authors: sakata m. Brain Behav. 2018 Dec;8(12):e01145. doi: 10.1002/brb3.1145. Epub 2018 Oct 24. Brain Behav. 2018. PMID: 30358161 Free PMC article.
Effects of multisession transcranial direct current stimulation as an augmentation to cognitive tasks in patients with neurocognitive disorders in Japan: a study protocol for a randomised controlled trial.
Inagawa T, Yokoi Y, Yamada Y, Miyagawa N, Otsuka T, Yasuma N, Omachi Y, Tsukamoto T, Takano H, Sakata M, Maruo K, Matsui M, Nakagome K. Inagawa T, et al. Among authors: sakata m. BMJ Open. 2020 Dec 23;10(12):e037654. doi: 10.1136/bmjopen-2020-037654. BMJ Open. 2020. PMID: 33361162 Free PMC article.
Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid.
Kasuga K, Kikuchi M, Tsukie T, Suzuki K, Ihara R, Iwata A, Hara N, Miyashita A, Kuwano R, Iwatsubo T, Ikeuchi T; Japanese Alzheimer’s Disease Neuroimaging Initiative. Kasuga K, et al. BMJ Neurol Open. 2022 Aug 10;4(2):e000321. doi: 10.1136/bmjno-2022-000321. eCollection 2022. BMJ Neurol Open. 2022. PMID: 36046332 Free PMC article.
930 results